BeStock  

Cellebrite CLBT

$11.20 +$0.13 (+1.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $11.15 -0.45%
Open$11.10
Prev close$11.07
Day range$10.97 – $11.34
Volume3.11M
Market cap$2.82B
P/E (TTM)48.7
Dividend yield–

Earnings

Average move on report day±9.4%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+20.7%
Worst reaction-29.2%

Stock move on the day after each report

+5.6%2023/Q3+11.0%2023/Q4+2.3%2024/Q1+7.3%2024/Q2-0.3%2024/Q3-12.9%2024/Q4-11.5%2025/Q1+9.3%2025/Q2+20.7%2025/Q3-4.6%2025/Q4+8.4%2026/Q1-29.2%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q213 Aug 2026Pre Market±10.8%-29.18%Bigger than priced
2026/Q114 May 2026Pre Market±10.7%+8.43%Within range
2025/Q411 Feb 2026Pre Market±10.5%-4.55%Within range
2025/Q312 Nov 2025After Market±17.7%+20.73%Bigger than priced
2025/Q214 Aug 2025Pre Market±14.4%+9.29%Within range
2025/Q114 May 2025Pre Market±12.3%-11.48%Within range
2024/Q413 Feb 2025Pre Market±14.9%-12.92%Within range
2024/Q36 Nov 2024Pre Market±15.4%-0.31%Within range
2024/Q215 Aug 2024Pre Market±15.1%+7.32%Within range
2024/Q123 May 2024Pre Market±15.4%+2.33%Within range
2023/Q415 Feb 2024Pre Market±15.3%+10.95%Within range
2023/Q314 Nov 2023Pre Market±6.0%+5.57%Within range
2023/Q28 Aug 2023Pre Market±16.3%+8.96%Within range
2023/Q110 May 2023Pre Market±23.5%-3.30%Within range
2022/Q415 Feb 2023Pre Market±14.5%+13.90%Within range
2022/Q317 Nov 2022Pre Market±19.3%-1.22%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$475.68M+18.6% YoY
Operating profit$66.48M+16.8% YoY
Net profit$78.33M+127.7% YoY
Diluted EPS$0.31+123.0% YoY

Profitability & balance sheet

Gross margin84.2%
Operating margin14.0%
Net margin16.4%
Return on equity19.0%
Return on assets9.6%
Return on invested capital13.5%
Current ratio1.56
Free cash flow / sales33.7%

Discussion

No comments yet — be the first to weigh in on CLBT.

Leave a comment

Scroll to Top